Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
23 participants
INTERVENTIONAL
2006-09-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients
NCT05442853
Continuous Glucose Monitoring in Inpatients
NCT06329297
Continuous Glucose Monitoring in Critically Ill Surgical Patients
NCT01108640
Pilot Study of Intensive Care Unit Continuous Glucose Monitoring
NCT01301053
Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Ill Patients
NCT02296372
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
POC Glucose Testing
Hourly blood glucose monitoring with point of care glucometer (i.e., current standard of care).
No interventions assigned to this group
Continuous Glucose Monitoring
Continuous arterial glucose monitoring with Guardian sensor + hourly blood glucose monitoring with point of care glucometer (i.e., current standard of care).
Continuous Glucose Monitoring
measure glucose levels on burn patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous Glucose Monitoring
measure glucose levels on burn patients
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-72 years old
* severe trauma or thermal injury greater than 20% TBSA burn
Exclusion Criteria
* myocardial infarction
* pre-existing renal failure or liver failure
* history of hypoglycemia
* history or high risk of seizures
* pregnancy
18 Years
72 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Army Institute of Surgical Research
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heather Pidcoke, MD
Role: PRINCIPAL_INVESTIGATOR
US Army Institute of Surgical Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
US Army Institute of Surgical Research
Fort Sam Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kerr D. Continuous blood glucose monitoring: detection and prevention of hypoglycaemia. Int J Clin Pract Suppl. 2001 Sep;(123):43-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-06-011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.